Search results
20 gru 2023 · Infected dog and cat bites - Antibiotic therapy. Choosing oral versus IV therapy; Oral regimens; Intravenous regimens; Duration of treatment; Spectrum of antibiotic coverage - Debridement and surgical consultation; Uninfected dog and cat bites - Antibiotic prophylaxis. Indications for prophylaxis; Prophylactic antibiotic regimens - Wound management
Human and dog bites. 500–875 mg orally 2 times a day. For outpatients. Prophylaxis: Give for 3 days. Treatment: Give for 5–7 days. 1.5–3.0 g IV every 6 hours. For inpatients. Effective against alpha-hemolytic streptococci, Staphylococcus aureus, and Eikenella corrodens. plus. 160/800 mg IV every 12 hours
The main factors determining management are the location, depth of the bite, whether inflicted by a human or animal, and the species of the animal. Co-amoxiclav is the antibiotic of choice for prophylaxis and treatment, unless contraindicated.
Our randomized controlled trial found that the overall infection rate of dog bite wounds was 2% (95% CI 0–7%) with a difference of 4% (95% CI −1–4.5%) between treatment and placebo groups. Based on the cost-model, it is not cost effective to give prophylactic antibiotics at 2%, though it may be justifiable at the upper end of the 95% CI ...
Many of the pathogens associated with the bites are treatable with various and somewhat common antimicrobials, though some are less easy to access. Basic irrigation, debridement, and wound culture are common to almost every animal and should be the first step in treatment.
29 maj 2024 · Antibiotics — The most common complication of an animal bite is infection. Antibiotics are generally recommended to prevent infection in people with high-risk wounds, such as deep puncture wounds, wounds involving a bone or joint, and for people with other health problems, such as a weakened immune system or diabetes, which could increase the ...
30 sty 2019 · Infected animal bite wounds should be treated with an empiric antimicrobial agent, such as amoxicillin-clavulanate, that is active against both aerobic and anaerobic bacteria. For intravenous therapy, ampicillin-sulbactam or piperacillin-tazobactam may be used.
